Last10K.com

Mesoblast Ltd (MESO) SEC Filing 6-K Foreign Issuer Report for the period ending Tuesday, October 4, 2022

Mesoblast Ltd

HISTORY TOOLS
CIK: 1345099 Ticker: MESO

View differences made from one to another to evaluate Mesoblast Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mesoblast Ltd.

Continue

Assess how Mesoblast Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mesoblast Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Mesoblast Ltd provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: MESO
CIK: 1345099
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001564590-22-033508
Submitted to the SEC: Tue Oct 04 2022 9:13:58 PM EST
Accepted by the SEC: Wed Oct 05 2022
Period: Tuesday, October 4, 2022
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/meso/0001564590-22-033508.htm